A detailed history of Wells Fargo & Company transactions in Cytokinetics Inc stock. As of the latest transaction made, Wells Fargo & Company holds 57,534 shares of CYTK stock, worth $2.82 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
57,534
Previous 54,108 6.33%
Holding current value
$2.82 Million
Previous $2.93 Million 3.62%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$51.22 - $60.16 $175,479 - $206,108
3,426 Added 6.33%
57,534 $3.04 Million
Q2 2024

Aug 13, 2024

BUY
$47.86 - $75.05 $643,429 - $1.01 Million
13,444 Added 33.06%
54,108 $2.93 Million
Q1 2024

May 10, 2024

BUY
$63.75 - $108.06 $244,162 - $413,869
3,830 Added 10.4%
40,664 $2.85 Million
Q4 2023

Feb 09, 2024

SELL
$26.88 - $83.49 $1.28 Million - $3.97 Million
-47,596 Reduced 56.37%
36,834 $3.08 Million
Q3 2023

Nov 13, 2023

SELL
$29.46 - $36.61 $537,173 - $667,546
-18,234 Reduced 17.76%
84,430 $2.49 Million
Q2 2023

Aug 15, 2023

BUY
$32.62 - $40.75 $952,275 - $1.19 Million
29,193 Added 39.73%
102,664 $3.35 Million
Q1 2023

May 12, 2023

BUY
$33.36 - $45.71 $1.62 Million - $2.22 Million
48,592 Added 195.31%
73,471 $2.59 Million
Q4 2022

Feb 13, 2023

BUY
$35.77 - $51.11 $39,955 - $57,089
1,117 Added 4.7%
24,879 $1.14 Million
Q3 2022

Nov 14, 2022

SELL
$38.54 - $54.52 $28,326 - $40,072
-735 Reduced 3.0%
23,762 $1.15 Million
Q2 2022

Aug 12, 2022

SELL
$33.93 - $48.92 $2.86 Million - $4.13 Million
-84,324 Reduced 77.49%
24,497 $963,000
Q1 2022

May 16, 2022

SELL
$29.74 - $46.0 $284,165 - $439,530
-9,555 Reduced 8.07%
108,821 $4.01 Million
Q4 2021

Feb 14, 2022

BUY
$34.35 - $46.38 $1.22 Million - $1.65 Million
35,643 Added 43.08%
118,376 $5.4 Million
Q3 2021

Nov 15, 2021

BUY
$18.54 - $35.74 $736,019 - $1.42 Million
39,699 Added 92.25%
82,733 $2.96 Million
Q2 2021

Aug 16, 2021

SELL
$19.79 - $26.99 $772,284 - $1.05 Million
-39,024 Reduced 47.56%
43,034 $852,000
Q1 2021

May 13, 2021

SELL
$18.57 - $25.68 $1.41 Million - $1.95 Million
-75,844 Reduced 48.03%
82,058 $1.91 Million
Q4 2020

Feb 09, 2021

BUY
$15.26 - $28.61 $525,584 - $985,385
34,442 Added 27.9%
157,902 $3.28 Million
Q3 2020

Nov 05, 2020

SELL
$20.58 - $28.96 $177,481 - $249,751
-8,624 Reduced 6.53%
123,460 $2.67 Million
Q2 2020

Aug 13, 2020

BUY
$11.15 - $24.64 $107,630 - $237,849
9,653 Added 7.88%
132,084 $3.11 Million
Q1 2020

May 14, 2020

BUY
$8.75 - $16.3 $1.07 Million - $2 Million
122,431 New
122,431 $1.44 Million

Others Institutions Holding CYTK

About CYTOKINETICS INC


  • Ticker CYTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,144,096
  • Market Cap $4.62B
  • Description
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...
More about CYTK
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.